MacroGenics
MGNX
#9393
Rank
S$0.11 B
Marketcap
S$1.78
Share price
-0.72%
Change (1 day)
-60.87%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.35 Billion

According to MacroGenics's latest financial reports the company's total assets are S$0.35 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$0.35 B-9.76%
2023-12-31S$0.39 B4.82%
2022-12-31S$0.37 B-17.04%
2021-12-31S$0.45 B-9.55%
2020-12-31S$0.50 B18.93%
2019-12-31S$0.42 B-7.15%
2018-12-31S$0.45 B-9.26%
2017-12-31S$0.50 B11.01%
2016-12-31S$0.45 B-11.36%
2015-12-31S$0.50 B121.18%
2014-12-31S$0.22 B44.18%
2013-12-31S$0.15 B142.46%
2012-12-31S$65.72 M-19.03%
2011-12-31S$81.17 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Xencor
XNCR
S$1.12 B 220.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 76,989.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$167.87 B 47,744.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$75.85 B 21,517.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$116.81 B 33,191.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$148.94 B 42,348.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.55 B 35,683.69%๐Ÿ‡บ๐Ÿ‡ธ USA